Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine, Nature Biotechnology and Nature Reviews Drug Discovery.
August 2009
2009:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Chemical-safety costs uncertain
Researchers and regulators disagree on how European Union REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) legislation will affect costs and loss of animal lives.
Nature News (26 August 2009)
| Full Text |
US plans for science outreach to Muslim world
The administration of US President Barack Obama is ramping up plans to develop scientific and technological partnerships with Muslim-majority countries.
Nature News (26 August 2009)
| Full Text |
FDA narrows drug label usage
The US Food and Drug Administration (FDA) has altered the usage labels on two cancer drugs on the basis of a re-evaluation of clinical data.
Nature News (26 August 2009)
| Full Text |
DNA swap could avoid inherited diseases
A technique to transfer genetic material from one egg cell to another could be used to prevent the inheritance of diseases caused by faults in the DNA of mitochondria, the 'power plants' of the cell.
Nature News (26 August 2009)
| Full Text |
Japan relaxes human stem-cell rules
A long-sought loosening of Japan's guidelines on human embryonic stem-cell research came into effect on 21 August, but some say the new rules are too little, too late for a struggling field that was once a source of national pride.
Nature News (21 August 2009)
| Full Text |
Japan election sparks science pledges
The outcome of Japan's upcoming parliamentary elections could affect the scientific research and technology budget, as the incoming majority party must balance economic growth with pledges to cut wasteful spending.
Nature News (20 August 2009)
| Full Text |
Collins sets out his vision for the NIH
Francis Collins, the new director of the US National Institutes of Health (NIH), has laid out a five-point road map for the agency, which includes focusing greater attention on translational research, neglected diseases and health-care reform.
Nature News (20 August 2009)
| Full Text |
Cardiovascular disease gets personal
Doctors and scientists are hoping that treatment for cardiovascular disease — the world's top killer — will benefit from studies that have linked genetic variants to various cardiovascular conditions and to patients' responses to commonly prescribed drugs.
Nature News (20 August 2009)
| Full Text |
Awards bridge 'valley of death'
The National Cancer Institute (NCI) has named the first recipients of a new award designed to help companies developing promising cancer therapies overcome the so-called 'valley of death'.
Nature Biotechnology News (August 2009)
| Full Text |
Science advisers mull priorities
The US President's Council of Advisors on Science and Technology (PCAST) met publicly for the first time to discuss how science can help the economic recovery, and how best to deliver on President Obama's ambitious climate and energy research portfolio.
Nature News (13 August 2009)
| Full Text |
Flu database rocked by legal row
The international EpiFlu database was created to help monitor the spread and evolution of influenza viruses, but a legal dispute over ownership rights has cast doubts about its future.
Nature News (13 August 2009)
| Full Text |
Return of the rat
The European Commission has approved EURATRANS — a systems-biology program intended to expand databases of rat genes, proteins and other biomolecules.
Nature News (13 August 2009)
| Full Text |
Dismissal of bioethics council leads to speculation about its future
US President Barack Obama abruptly dissolved the President's Council on Bioethics in late June and is expected to name a new commission by this fall.
Nature Medicine News (August 2009)
| Full Text |
Sequencing push brings new UK genome analysis center
The UK Genome Analysis Centre (TGAC) hosts biologists and bioinformaticians who will perform genome sequencing on plants, animals and microbes and develop new bioinformatics tools for handling the data.
Nature Medicine News (August 2009)
| Full Text |
Cancer meeting in Germany highlights need for national registry
German policy makers, physician groups and information technology industry experts have expressed an urgent need for an overarching national cancer registry.
Nature Medicine News (August 2009)
| Full Text |
NIH stem cell rules expand funding
New stem cell funding guidelines issued by the US National Institutes of Health (NIH) have ended the 2001 restriction limiting federal funding to research involving just 21 usable human embryonic stem cell lines.
Nature Medicine News (August 2009)
| Full Text |
From cells, secrets of the secretome leak out
Secreted proteins from cells make up a rich, complex subset of molecules referred to as the 'secretome', and many researchers are focused on understanding links between the secretome and disease.
Nature Medicine News (August 2009)
| Full Text |
Greek scientists fight research shake-up
Greek researchers are fighting a major reorganization that will turn some research institutes into single-discipline centers and unite smaller institutes in the south and north into two regional centers.
Nature News (6 August 2009)
| Full Text |
Who speaks for science in Europe?
As the debate begins on what the European Union's next Framework Programme should look like, European scientists consider how they might more effectively shape science policy.
Nature News (6 August 2009)
| Full Text |
Grant scores leave applicants in limbo
Applicants for the coveted Challenge Grants issued by the US National Institutes of Health (NIH) as part of the American Recovery and Reinvestment Act have learned the peer-review scores for their proposals, but will have to wait until September to learn if their proposed projects will be funded.
Nature News (6 August 2009)
| Full Text |
Regulatory watch: IL-1β-targeted antibody approved for rare autoinflammatory disorders
Canakinumab, a human monoclonal antibody that targets interleukin 1β (IL-1β), was approved by the US Food and Drug Administration (FDA) for the treatment of a group of rare, long-term and potentially life-threatening autoinflammatory disorders.
Nature Reviews Drug Discovery News (August 2009)
| Full Text |
News in brief
| Conflict of interest and resignation at drug agency
| Peru embraces biotech
| Illumina's cut-price genome scan
| Stalled science buildings restart in California
| Novartis targeted by animal-rights extremists
| Lab worker charged with destroying protein crystals
| US report backs distinction between science and policy
| New ion channel database available online
| FDA allows further development of Oxford Biomedica's cancer vaccine
News Features
Medicine: Last chance clinic
The NIH's Undiagnosed Diseases Program aims to identify and characterize previously unknown diseases by drawing on the institution's 6,000 clinical and biomedical experts and the medical technologies at their fingertips.
Nature News (26 August 2009)
| Full Text |
Mouse genetics: The check-up
The German Mouse Clinic provides comprehensive physiological data on genetically engineered mouse strains — but the waiting list is likely to grow longer as researchers develop more complex mouse models in an effort to recapitulate human disease.
Nature News (20 August 2009)
| Full Text |
Immunology's quiet upheaval
As autoimmune disease therapies advance in the clinic, new discoveries are challenging the fundamental principle that T-cell lineages, once established, don't change.
Nature Biotechnology News (August 2009)
| Full Text |
|
